 Home > Medical News > Medicines Company News > Biosafety (Nantong) New Drug Creation Base Launched and Biotop Animal Brand Launch Conference

Biosafety (Nantong) New Drug Creation Base Launched and Biotop Animal Brand Launch Conference

 Last Update: 2021-07-08
 Source: Internet
 Author: User

Tags

doxycycline animals

life support system

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In recent years, the global biomedical industry has developed rapidly and is gradually becoming the leading industry in the world economy
.

Innovative animal models are irreplaceable core biological resources in global biomedicine research and development.

Based on the global biopharmaceutical industry, BioMice established the "BioMice" brand from technological innovation, covering innovative animal model research and development, production, supply and services, shortening the pharmaceutical research and development cycle and improving research and development efficiency.
Has a significant role in promoting
.

As a key link in the pharmaceutical R&D outsourcing organization (CRO) industry chain, the innovation model will further improve the biomedical industry innovation chain and promote the development of disease treatment and new drug research and development

In order to help the development of the pharmaceutical industry, the Jiangsu Province-level major project "Biosaitu (Nantong) New Drug Creation Base" has a building area of 126,000 square meters, which has been officially completed at the end of 2020
.

Biocytometer and Haimen Science and Technology Park will jointly host the "Biocytometer (Nantong) New Drug Creation Base Launching and Biocommunity Brand Release Conference" on April 24, 2021

Meeting information

The theme of the
conference is the launch of Biocytogram (Nantong) new drug creation base and the concurrent forum of the Biopharmaceutical brand release conference
: innovative models to help biomedicine

Organizer
Biocytogen Jiangsu Gene Biotechnology Co.

, Ltd.

Co-hosted the Laboratory Animal Management Working Committee of the Outsourcing R&D Service Organization of the Chinese Society of Laboratory Animals in
Haimen Science Park

Meeting time
April 24, 2021

Conference Venue
: Lecture Hall, Floor 1, Floor A, Biomedical Pioneer Park, Haimen District, Nantong, Jiangsu

Meeting schedule

In the morning on April 24, 2021,
Biosaito (Nantong) New Drug Creation Base Launched and Biotop Animal Brand Launch Conference

09:00-09:05
Opening Ceremony

09:05-09:15
Speech by the leader of the Haimen District Government of Nantong City

09:15-09:25
Speech by the leader of Haimen Science and Technology Park

09:25-09:40
Introduction of the BIO animal brand
Shen Yuelei Chairman and CEO BIO (Beijing) Pharmaceutical Technology Co.

, Ltd.

09:40-09:45
Speech by Laboratory Animal Experts
He Zhengming, Vice Chairman,
National Laboratory Animal Expert Committee

09:45-10:05 Baiao
Animal New Product Release
Zhang Haichao, Director
of Operations Baiao Cyto (Beijing) Pharmaceutical Technology Co.

, Ltd.

10:05-10:30
Development of Respiratory System Antibody Drugs
Zhang Chenghai Founder and CEO
Shanghai Maiji Biotechnology Co.

, Ltd.

10:30-10:50
Base launch and brand launch ceremony & signing ceremony

10:50-12:00
Visit to Biosaitu (Nantong) New Drug Creation Base

12:00-13:30
lunch

In the afternoon of April 24, 2021,
"Innovative Models, Boosting Biomedicine" Forum

13:30-13:35
Welcome speech

13:35-14:00
Strategy analysis to strengthen the correlation between preclinical efficacy evaluation test results and clinical research
Chen Yue, General Manager
Chengdu Hetuo Chuangzhan Biotechnology Co.

, Ltd.

14:00-14:25
Analysis of the advantages of humanized animals in the development of antibody drugs
Li Dirui, Manager of Pharmacology and Pharmacodynamics Department
Biocytometer (Beijing) Pharmaceutical Technology Co.
, Ltd.

14:25-14:50
From the perspective of biosafety law to see the safety management of
laboratory animal facilities Shao Qiming, head of laboratory animal facility operations in
China, Jackson Laboratory China

14:50-15:15
CRO laboratory animal institution accreditation preparation and the gains and experience in the improvement of the quality system
Xie Xiaojie, director of laboratory animal management,
Chengdu Huaxi Haiqi Pharmaceutical Technology Co.
, Ltd.

15:15-15:30
tea break

15:30-15:55 Application of
Exhaust Pipe Dust Detection in SPF Facilities Laboratory Animal Microbiological Quality Monitoring
Guo Lianxiang Deputy General Manager
Suzhou Xishan Biotechnology Co.
, Ltd.

15:55-16:20
Pay attention to the nutritional level of vitamins in rat food and its effect on the health of laboratory rats
Cui Jinpeng Deputy General Manager
Shanghai Front Animal Health Co.
, Ltd.

16:20-16:45
Construction of Primate Behavior Evaluation System
Nan Zhenhong Director of
Neuropharmacology Zhao Yan (Suzhou) New Drug Research Center Co.
, Ltd.

16:45-17:10
Current situation analysis of experimental monkey resources and countermeasures
Pan Xueying Chief Veterinarian
Shanghai Innos Biotechnology Co.
, Ltd.

17:10-17: 35Tang Xiaojiang, the
world's first intracellular heavy metal repellent and animal experiment platform,
Chairman of
Zhuhai Bestton Biotechnology Co.
, Ltd.

18:00-20:00
Dinner

Sponsorship and cooperation media

Sponsor

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.